A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]☆
Under an Elsevier user license
open archive
Keywords
augmented cost-effectiveness analysis
benefit-cost analysis
multi-criteria decision analysis
value frameworks
Cited by (0)
- ☆
Conflicts of interest: D. N. Lakdawalla is a consultant to Precision Health Economics and an investor in its parent company, Precision Medicine Group. The authors state that no ethical approval was needed. The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the agencies or organizations with which the authors are affiliated.
© 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.